{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:15:13Z","timestamp":1574468113524},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T00:00:00Z","timestamp":1256083200000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00774-009-0131-1","type":"article-journal","created":{"date-parts":[[2009,10,20]],"date-time":"2009-10-20T19:21:05Z","timestamp":1256066465000},"page":"314-319","source":"Crossref","is-referenced-by-count":5,"title":"Serum homocysteine, folate and vitamin B12 in patients with Paget\u2019s disease of bone: the effect of zoledronic acid","prefix":"10.1007","volume":"28","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Litsas","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Panagiotou","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Arsos","sequence":"additional","affiliation":[]},{"given":"Efstratios","family":"Moralidis","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Barmpalios","sequence":"additional","affiliation":[]},{"given":"Efthimia","family":"Zafeiriadou","sequence":"additional","affiliation":[]},{"given":"Efthimia","family":"Triantafillidou","sequence":"additional","affiliation":[]},{"given":"Eleni","family":"Makrigiannaki","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,10,21]]},"reference":[{"key":"131_CR1","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E (2009) Paget\u2019s disease of bone: emphasis on treatment with zoledronic acid . Expert Rev Endocrinol Metab 4:423\u2013434","DOI":"10.1586\/eem.09.35","doi-asserted-by":"crossref"},{"key":"131_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(08)61035-1","volume":"372","author":"SH Ralston","year":"2008","unstructured":"Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget\u2019s disease of bone. Lancet 372:155\u2013163","journal-title":"Lancet"},{"key":"131_CR3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-006-0696-x","volume":"24","author":"S Takata","year":"2006","unstructured":"Takata S, Hashimoto J, Nakatsuka K, Yoshimura N, Yoh K, Ohno I, Yabe H, Abe S, Fukunaga M, Terada M, Zamma M, Ralston SH, Morii H, Yoshikawa H (2006) Guidelines for diagnosis and management of Paget\u2019s disease of bone in Japan. J Bone Miner Metab 24:359\u2013367","journal-title":"J Bone Miner Metab"},{"key":"131_CR4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-008-0629-8","volume":"19","author":"JP Devogelaer","year":"2008","unstructured":"Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, Goemaere S, Kaufman JM, Reginster JY, Rozenberg S, Boonen S (2008) Management of patients with Paget\u2019s disease: a consensus document of the Belgian Bone Club. Osteoporos Int 19:1109\u20131117","journal-title":"Osteoporos Int"},{"key":"131_CR5","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou Z, Kita M, Litsas I, Avramidis A, Arsos G, Moralidis E, Gerou S, Pavlidou V, Papatheodorou A, Terpos E (2009) The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin and RANKL in patients with Paget\u2019s disease of bone. Horm Metab Res 41. doi: 10.1055\/s-0029-1233491 [Epub ahead of print]","DOI":"10.1055\/s-0029-1233491","doi-asserted-by":"crossref"},{"key":"131_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/15648265080292S116","volume":"29","author":"J Selhub","year":"2008","unstructured":"Selhub J (2008) Public health significance of elevated homocysteine. Food Nutr Bull 29:116\u2013125","journal-title":"Food Nutr Bull"},{"key":"131_CR7","first-page":"1621","volume":"45","author":"M Herrmann","year":"2007","unstructured":"Herrmann M, Peter SJ, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, Colaianni G, Wildemann B, Herrmann W (2007) The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 45:1621\u20131632","journal-title":"Clin Chem Lab Med"},{"key":"131_CR8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00296-008-0640-6","volume":"28","author":"M Colina","year":"2008","unstructured":"Colina M, La CR, De LF, Trotta F (2008) Paget\u2019s disease of bone: a review. Rheumatol Int 28:1069\u20131075","journal-title":"Rheumatol Int"},{"key":"131_CR9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-008-0852-6","volume":"26","author":"A Avramidis","year":"2008","unstructured":"Avramidis A, Polyzos SA, Moralidis E, Arsos G, Efstathiadou Z, Karakatsanis K, Grollios G, Kita M (2008) Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget\u2019s disease of bone. J Bone Miner Metab 26:635\u2013641","journal-title":"J Bone Miner Metab"},{"key":"131_CR10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med 353:898\u2013908","journal-title":"N Engl J Med"},{"key":"131_CR11","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E (2009) Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid. Support Care Cancer 17:1329\u20131330","DOI":"10.1007\/s00520-009-0704-5","doi-asserted-by":"crossref"},{"key":"131_CR12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jbmr.5650110206","volume":"11","author":"SA Khan","year":"1996","unstructured":"Khan SA, McCloskey EV, Eyres KS, Nakatsuka K, Sirtori P, Orgee J, Coombes G, Kanis JA (1996) Comparison of three intravenous regimens of clodronate in Paget disease of bone. J Bone Miner Res 11:178\u2013182","journal-title":"J Bone Miner Res"},{"key":"131_CR13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2008.10.051","volume":"44","author":"M Herrmann","year":"2009","unstructured":"Herrmann M, Tami A, Wildemann B, Wolny M, Wagner A, Schorr H, Taban-Shomal O, Umanskaya N, Ross S, Garcia P, Hubner U, Herrmann W (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:467\u2013475","journal-title":"Bone"},{"key":"131_CR14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1359\/jbmr.060406","volume":"21","author":"JM Koh","year":"2006","unstructured":"Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21:1003\u20131011","journal-title":"J Bone Miner Res"},{"key":"131_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00223-009-9244-8","volume":"84","author":"BL Vaes","year":"2009","unstructured":"Vaes BL, Lute C, Blom HJ, Bravenboer N, de Vries TJ, Everts V, Dhonukshe-Rutten RA, Muller M, de Groot LC, Steegenga WT (2009) Vitamin B(12) deficiency stimulates osteoclastogenesis via increased homocysteine and methylmalonic acid. Calcif Tissue Int 84:413\u2013422","journal-title":"Calcif Tissue Int"},{"key":"131_CR16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1582-4934.2008.00104.x","volume":"12","author":"M Herrmann","year":"2008","unstructured":"Herrmann M, Umanskaya N, Wildemann B, Colaianni G, Widmann T, Zallone A, Herrmann W (2008) Stimulation of osteoblast activity by homocysteine. J Cell Mol Med 12:1205\u20131210","journal-title":"J Cell Mol Med"},{"key":"131_CR17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/00365510701342088","volume":"67","author":"S Ozdem","year":"2007","unstructured":"Ozdem S, Samanci S, Tasatargil A, Yildiz A, Sadan G, Donmez L, Herrmann M (2007) Experimental hyperhomocysteinemia disturbs bone metabolism in rats. Scand J Clin Lab Invest 67:748\u2013756","journal-title":"Scand J Clin Lab Invest"},{"key":"131_CR18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.293.9.1082","volume":"293","author":"Y Sato","year":"2005","unstructured":"Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293:1082\u20131088","journal-title":"JAMA"},{"key":"131_CR19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/85.2.460","volume":"85","author":"TJ Green","year":"2007","unstructured":"Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ (2007) Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr 85:460\u2013464","journal-title":"Am J Clin Nutr"},{"key":"131_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10654-009-9340-0","volume":"24","author":"L Ruan","year":"2009","unstructured":"Ruan L, Chen W, Srinivasan SR, Xu J, Toprak A, Berenson GS (2009) Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study. Eur J Epidemiol 24:315\u2013319","journal-title":"Eur J Epidemiol"},{"key":"131_CR21","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"J Selhub","year":"1993","unstructured":"Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693\u20132698","journal-title":"JAMA"},{"key":"131_CR22","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1021\/bm050273s","volume":"6","author":"S Zhang","year":"2005","unstructured":"Zhang S, Wright JE, Bansal G, Cho P, Uludag H (2005) Cleavage of disulfide-linked fetuin-bisphosphonate conjugates with three physiological thiols. Biomacromolecules 6:2800\u20132808","journal-title":"Biomacromolecules"},{"key":"131_CR23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0026-0495(94)90078-7","volume":"43","author":"ME Melton","year":"1994","unstructured":"Melton ME, Kochman ML (1994) Reversal of severe osteoporosis with vitamin B12 and etidronate therapy in a patient with pernicious anemia. Metabolism 43:468\u2013469","journal-title":"Metabolism"},{"key":"131_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00296-008-0693-6","volume":"29","author":"I Bayhan","year":"2009","unstructured":"Bayhan I, Uygur D, Ugurlu N, Ozaksit G (2009) Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women. Rheumatol Int 29:263\u2013266","journal-title":"Rheumatol Int"},{"key":"131_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bone.2004.03.023","volume":"35","author":"IR Reid","year":"2004","unstructured":"Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T (2004) Comparative responses of bone turnover markers to bisphosphonate therapy in Paget\u2019s disease of bone. Bone 35:224\u2013230","journal-title":"Bone"}],"container-title":"Journal of Bone and Mineral Metabolism","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0131-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-009-0131-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0131-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:26Z","timestamp":1559110466000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,21]]},"references-count":25,"journal-issue":{"published-print":{"date-parts":[[2010,5]]},"issue":"3"},"alternative-id":["131"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00774-009-0131-1","relation":{"cites":[]},"ISSN":["0914-8779","1435-5604"],"subject":["Endocrinology, Diabetes and Metabolism","Endocrinology","Orthopedics and Sports Medicine","General Medicine"],"container-title-short":"J Bone Miner Metab"}